Latest news with #CNW
Cision Canada
26 minutes ago
- Business
- Cision Canada
Royal LePage Benchmark Partners with Virtuo to Elevate the Agent and Client Experience
Partnership enables one of Alberta's leading brokerages to empower agents to deliver seamless, personalized, AI-empowered homeownership journeys. CALGARY, AB, July 23, 2025 /CNW/ - Virtuo, the AI-powered agent and buyer success platform that streamlines the homeownership journey, announced today a strategic partnership with Royal LePage Benchmark. Alberta's high-performing real estate brokerage will leverage Virtuo to equip their agents with an all-in-one platform to grow their business and enhance client experiences. With more than 200 agents, Royal LePage Benchmark is the largest Royal LePage franchise in Alberta and has built a reputation for excellence since its founding in 1978. Led by Corinne Lyall, the brokerage is committed to equipping its agents with innovative tools to differentiate themselves in the marketplace and live by its vision of "Helping You Is What We Do ®." "We are always looking for ways to support our agents in providing an exceptional client experience," said Lyall, Broker and Owner of Royal LePage Benchmark. "Virtuo gives our agents instant access to all brokerage tools in one platform while delivering a differentiated experience to their clients. This partnership is an investment in our agents and their success." Virtuo combines AI-driven technology with a human-led approach to enhance every stage of the homeownership experience. To date, Virtuo has helped 30,000 homebuyers transform the most stressful aspects of moving. HomieAI™ is designed specifically for individual agents and the homes they represent, delivering personalized insights and answering questions instantly, 24/7. Unlike generic chatbots, it draws from unique data provided by the agent, brokerage, and property to create a tailored experience for both clients and real estate professionals. Benchmark agents will benefit from Virtuo's AI-powered platform that delivers access to all the brokerage's tools, consistent branding and the ability to offer a differentiated experience that begins as soon as their clients go under contract on a home and extends through their homeownership journey. "Our collaboration with Royal LePage Benchmark marks a pivotal moment in real estate innovation and a shared vision of empowering agents with smart technology to create outstanding customer experience," said Virtuo Co-Founder and CEO Casey Kachur. "By leveraging AI to augment the personal touch, we're setting a new standard for real estate professionals, not just improving the agent and client experience – we're redefining it." About Royal LePage Benchmark Royal LePage Benchmark is a respected, award-winning, family-owned real estate brokerage based in Calgary, Alberta. With a proud history dating back to 1978, we've served Alberta communities for over 45 years. Originally launched under the Realty World brand, the company evolved under the leadership of founder Jan Lyall and her daughter Corinne Lyall, who became Broker/Owner in 2008. Today, Royal LePage Benchmark is home to over 200 full-time REALTORS® and a robust support team across multiple Alberta locations, including Calgary, Cochrane, Strathmore, Airdrie, and Fort McMurray. The brokerage has been nationally recognized with the Royal LePage Canada Brokerage of the Year (2020), Prairies Brokerage of the Year, and several National Technology, Charitable, and Recruiter of the Year awards. Led by Corinne Lyall and a dedicated leadership team, Royal LePage Benchmark is known for its commitment to professionalism, agent development, community involvement, and integrity. With a legacy of excellence and innovation, we continue to support our clients and REALTORS® with the tools, coaching, and culture to thrive. For more information, visit About Virtuo Virtuo is the leading AI-powered home concierge platform, streamlining the homeownership journey for builders, brokerages and service providers. By seamlessly integrating advanced technology with personalized service, Virtuo ensures a smooth experience from contract to move-in and beyond. Learn more at
Cision Canada
26 minutes ago
- Business
- Cision Canada
INVESTIGATION ALERT: Berger Montague is Investigating Securities Fraud Claims on Behalf of ASCOT RESOURCES LTD. (AOT.TO; AOTVF; BHQ.F; BHQ.DU; BHQ.MU) Investors
PHILADELPHIA, /CNW/ -- Berger Montague, with offices in Canada and throughout the United States, is currently investigating potential violations of the federal securities laws on behalf of shareholders of Ascot Resources Ltd. ("Ascot" or the "Company") ( AOTVF; BHQ.F; Ascot, headquartered in Vancouver, BC, engages in the exploration and development of mineral properties in the United States and Canada. Its main asset is known as the Premier Gold Project ("PGP") in Western Canada. Between January 22 and September 5, 2024, AOT reported that after its February 22, 2024 offering of securities that it would be fully-funded to complete the construction of the PGP Project, progress through the ramp-up phase to commercial production and "steady state operations." The Company also reported that commercial production was anticipated to happen during Q3 2024, and as a result it would be self-funded for at least twelve months out. On September 6, 2024, the Company abruptly reversed course on its plans for the PGP mine, reporting multiple operational issues and suspending all operations until additional capital was raised. Following these revelations, the price of Ascot securities suffered substantial declines on abnormally high volume. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE. The Firm has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States and Canada. Contacts: Andrew Morganti, Shareholder (647) 576-7840 ext. 101 [email protected] Andrew Abramowitz, Senior Counsel (215) 875-3015 [email protected] SOURCE Berger Montague
Malaysian Reserve
an hour ago
- Health
- Malaysian Reserve
British Columbia Joins Other Provincial Public Drug Plans Now Reimbursing FOQUEST® on their Formulary for Attention Deficit Hyperactivity Disorder (ADHD)
TORONTO, July 23, 2025 /CNW/ – Elvium Life Sciences is pleased to announce the addition of FOQUEST® (methylphenidate hydrochloride controlled release capsules) to the British Columbia1 PharmaCare formulary and First Nations Health Authority (FNHA) Pharmacy Benefit. With provincial funding in place in British Columbia, FOQUEST® is now reimbursed from coast to coast on all provincial drug plans across Canada. 'Public funding in British Columbia ensures equitable access to ADHD treatments in BC,' said Juanita Beaudry, Executive Director of the Centre for ADHD Awareness (CADDAC) 'This latest approval now provides access across Canada to another treatment option for patients.' British Columbia now joins Alberta2, Saskatchewan3, Manitoba4, Ontario5, Quebec6, Atlantic Canada7,8,9,10, the Non-Insured Health Benefit Plan11 and Correctional Service Canada in providing public formulary coverage for FOQUEST® for the treatment of ADHD in patients aged six years and older. 'Elvium Life Sciences is very pleased that British Columbia has now included Foquest on the BC PharmaCare Formulary to give physicians an additional choice for their ADHD patients who require public coverage,' said Jodan Ratz, Country Medical Director at Elvium Life Sciences. 'We thank the province for its decision which now means that all ADHD patients aged six years of age and older have equivalent access to Foquest should this be the right treatment for them.' See the full Canadian Product Monograph for FOQUEST®12 The Product Monograph for FOQUEST® contains a Serious Warning and Precaution for drug dependence, emphasizing that abuse of FOQUEST® can lead to dependence. Healthcare professionals should assess the risk of abuse prior to prescribing FOQUEST®, including in patients with a history of drug dependence or alcoholism, and monitor for signs of abuse and dependence while patients are on therapy. FOQUEST® is a once-daily, long-acting methylphenidate controlled-release capsule for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients greater than or equal to six years of age. The maximum daily dose of FOQUEST® for children and adolescents (6 to <18 years old) is 70mg, and the maximum daily dose for adults (≥18 years old) is 100 mg. Adverse events observed with FOQUEST® treatment mainly reflect side effects commonly associated with methylphenidate use. Very common adverse events reported by patients treated with FOQUEST® were headache, insomnia, decreased appetite and abdominal pain. Most of the events were mild to moderate in severity. About Elvium Life Sciences Elvium Life Sciences is an independent associated company of Purdue Pharma (Canada), that focuses on specialty pharmaceutical products committed to providing treatment options for patients who suffer from the symptoms of Attention Deficit/Hyperactivity Disorder (ADHD) and products for ophthalmology. For more information, please visit FOQUEST® is a registered trademark of Purdue Pharma and is used under licence. References: 1. Available at: Accessed July 23, 2025 2. Available at: Accessed July 18, 2025 3. Available at: Accessed July 18, 2025 4. Available at: Accessed July 18, 2025 5. Available at: Accessed July 18, 2025 6. Available at: Accessed July 18, 2025 7. Available at: Accessed July 18, 2025 8. Available at: Accessed July 18, 2025 9. Available at: Accessed July 18, 2025 10. Available at: Accessed July 18, 2025 11. Available at: Accessed July 18, 2025. 12. Available at:
Cision Canada
an hour ago
- Business
- Cision Canada
PIZZA PIZZA ROYALTY CORP. ANNOUNCES JULY DIVIDEND and TIMING OF SECOND QUARTER 2025 RESULTS
TORONTO, July 23, 2025 /CNW/ - Pizza Pizza Royalty Corp. (the "Company") (TSX: PZA) today announced its monthly cash dividend of $0.0775 per share for July 2025. The dividend will be payable to shareholders of record at the close of business July 31, 2025, and will be paid on August 15, 2025. For tax purposes, the 2025 dividend will be considered a taxable eligible dividend. The Company also announced that its financial results for the second quarter ended June 30, 2025 will be issued after markets close on August 7, 2025. The Company invites analysts and portfolio managers to participate in a conference call with Pizza Pizza Management. The call will take place on August 7, 2025 at 5:30 p.m. Shareholders and media are invited to listen to the call. Details of the Conference Call: and or
Cision Canada
an hour ago
- Health
- Cision Canada
MEDIA ADVISORY - Minister Michel to participate in an event hosted by Foundation for Black Communities in Montréal Français
GATINEAU, QC, July 23, 2025 /CNW/ - The Minister of Health, the Honourable Marjorie Michel, will deliver remarks at the Black Ideas Grant (B.I.G) 2.0 event in Montréal. Minister Michel is attending on behalf of the Honourable Patty Hajdu, Minister of Jobs and Families and Minister responsible for the Federal Economic Development Agency for Northern Ontario. Please note that all details are subject to change. Date: Thursday, July 24, 2025 Time: 5:15 p.m. EDT Place: N/A & CO Inc. 9494 Saint- Laurent Boulevard, Suite 1020 (10 th floor) Montréal, Quebec Notes for media: To register, contact [email protected] with your name and media outlet. Follow us on X (Twitter)
